REZOLUTE, INC. Stock Issued During Period, Value, Issued for Services
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- REZOLUTE, INC. stock issued during period, value, issued for services for the quarter ending 2021-09-30 was $450.00K.
- REZOLUTE, INC. stock issued during period, value, issued for services for the quarter ending 2021-06-30 was $1.00K.
- REZOLUTE, INC. stock issued during period, value, issued for services for the quarter ending 2021-03-31 was $0.00.
- REZOLUTE, INC. stock issued during period, value, issued for services for the quarter ending 2020-12-31 was $7.00K.
- REZOLUTE, INC. stock issued during period, value, issued for services for fiscal 2021 was $8.00K.
- REZOLUTE, INC. stock issued during period, value, issued for services for fiscal 2019 was $12.00K, a 97.82% decline from fiscal 2018.
- REZOLUTE, INC. stock issued during period, value, issued for services for fiscal 2018 was $550.00K.
- REZOLUTE, INC. stock issued during period, value, issued for services for fiscal 2015 was $368.42K, a 8.94% decline from fiscal 2014.
| Period end | Stock Issued During Period, Value, Issued for Services 3 month | Stock Issued During Period, Value, Issued for Services 12 month |
|---|---|---|
| 2021-09-30 | $450.00K 10-Q · filed 2021-11-12 | $458.00K derived: sum of 4 quarters · filed 2022-09-15 |
| 2021-06-30 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-15 | $8.00K 10-K · filed 2022-09-15 |
| 2021-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-05-12 | |
| 2020-12-31 | $7.00K 10-Q · filed 2022-02-09 | |
| 2019-06-30 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-10-13 | $12.00K 10-K · filed 2020-10-13 |
| 2019-03-31 | $4.00K 10-Q · filed 2020-05-14 | |
| 2018-06-30 | $550.00K 10-K · filed 2019-09-10 | |
| 2015-06-30 | $70.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-28 | $368.42K 10-K · filed 2016-09-28 |
| 2015-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-15 | |
| 2014-12-31 | $60.42K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-02-17 | |
| 2014-09-30 | $238.00K 10-Q · filed 2014-11-12 | |
| 2014-06-30 | $404.59K 10-K · filed 2015-09-28 | |
| 2012-06-30 | $4.50K 10-K/A · filed 2012-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |